drugset / Trial / NCT05542849
The Efficacy and Tolerability of Acarbose in Healthy Individuals
Non-randomizedParallel-groupOpen-labelPrevention
Summary
A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.
Timeline
- Start
- 2022-08-10
- Primary completion
- 2022-10-05
- Completion
- 2022-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acarbose | Unknown | 50 mg | — |
Indications
No indication recorded.